Nucleic acid detection method for Chlamydia psittaci based on RPA-CRISPR/Cas12a
Letters in Applied Microbiology · 2025
DOI: 10.1093/lambio/ovaf138 ↗Kurz gefasst
Fachartikel in der Zeitschrift Letters in Applied Microbiology, 2025. Verfasst von Qiong Li und 6 weiteren Autor:innen. Beteiligte Einrichtung: Pathogen Inspection Center, Changzhou Center for Disease Prevention and Control, 203 TaiShan Road, Changzhou 213022 Jiangsu, China. Hauptthemen laut MEDLINE: Chlamydophila psittaci, Psittacosis, CRISPR-Cas Systems, Nucleic Acid Amplification Techniques. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 37 Literaturangaben. Gefördert von: Key Research and Development Project of Jiangsu Province, Jiangsu Provincial Commission of Health Project, Key Project of the Jiangsu Provincial Commission of Health.
Abstract (Originalsprache)
In recent years, misdiagnosis or delayed diagnosis of Chlamydia psittaci (C. psittaci) infections has led to frequent outbreaks of severe public health events, such as severe pneumonia and respiratory distress, drawing increasing attention. Rapid and simple detection methods are vital for early intervention to reduce severity and mortality. In this study, we designed highly specific RPA primers and crRNA (CRISPR RNA) based on the highly conserved CPSIT_0429 gene in the C. psittaci genome, and preliminarily established a nucleic acid detection method for C. psittaci using the RPA-CRISPR/Cas12a system. In the two-step assay, the combination of the CPSIT_0429-F1/R1 primer pair and CPSIT_0429-crRNA2 achieved a detection limit of 2 × 10° copies/μL. Incorporating 20% glycerol enabled a one-tube assay with a limit of 2 × 102 copies/μL. Furthermore, the method showed no cross-reactivity with common respiratory pathogens such as influenza virus, SARS-CoV-2, and Streptococcus pneumoniae, demonstrating excellent specificity. Both the two-step and one-tube methods were compared with qPCR-verified C. psittaci positive samples. The results indicated that both assays showed high consistency with qPCR results. The RPA-CRISPR/Cas12a detection method is rapid, accurate, highly sensitive, and specific, providing a reliable platform for early diagnosis and clinical management of C. psittaci infections.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Pathogen Inspection Center, Changzhou Center for Disease Prevention and Control, 203 TaiShan Road, Changzhou 213022 Jiangsu, China.
ORCID-Profile: Xujian Mao
Förderung
- Key Research and Development Project of Jiangsu Province
- Jiangsu Provincial Commission of Health Project
- Key Project of the Jiangsu Provincial Commission of Health
- Jiangsu Province Preventive Medicine Research Project
- Jiangsu Provincial Blood Parasite and Endemic Disease Prevention Research Project of China
- Changzhou science and technology Foundation
- Nanjing Medical University
Zitieren
APA
Li, Q., Xu, J., Jiang, J., Gong, L., Mao, X., Wang, F., & Yao, P. (2025). Nucleic acid detection method for Chlamydia psittaci based on RPA-CRISPR/Cas12a. Letters in Applied Microbiology. https://doi.org/10.1093/lambio/ovaf138
Vancouver
Li Q, Xu J, Jiang J, Gong L, Mao X, Wang F, et al. Nucleic acid detection method for Chlamydia psittaci based on RPA-CRISPR/Cas12a. Letters in Applied Microbiology. 2025. doi:10.1093/lambio/ovaf138
BibTeX
@article{Li2025,
author = {Li, Qiong and Xu, Jian and Jiang, Jinyi and Gong, Li and Mao, Xujian and Wang, Fengming and Yao, Ping},
title = {Nucleic acid detection method for Chlamydia psittaci based on RPA-CRISPR/Cas12a},
journal = {Letters in Applied Microbiology},
year = {2025},
doi = {10.1093/lambio/ovaf138}
}
EUVIMED